Antibody invented at Charlotte shows promise for pancreatic cancer treatment

An antibody that was invented at UNC Charlotte could be used to curb pancreatic cancer relapse and metastasis, a new UNC Charlotte study has found.

Pancreatic cancer is the 10th most common type of cancer, but it is the fourth-leading cause of cancer death among men and women in the United States.

Each November, Pancreatic Cancer Awareness Month calls attention to this silent killer. The cancer has very few symptoms, especially in early stages, meaning it often spreads and forms additional tumors before it is diagnosed.

Yet, there is hope for improved treatment options. UNC Charlotte researchers are among those leading the search for solutions, including research by Mukulika Bose ’22 Ph.D. and collaborators, including Bose’s mentor Pinku Mukherjee, published in the journal Translational Research.

Antibody invented at Charlotte shows promise for pancreatic cancer treatment